? Call for Submissions – Middle Eastern Cancer and Oncology Journal (MECOJ)
We are pleased to announce that the Middle Eastern Cancer and Oncology Journal (MECOJ) has officially obtained its ISSN number,
Can Bacteria Be Modified to Kill Cancer? A New Frontier in Oncology
In the ever-evolving world of cancer research, one of the most intriguing and promising frontiers is the use of bacteria—yes,
Understanding Biological Ageing: A Key Factor in Cancer Survivorship
What is Biological Ageing? Biological ageing refers to the gradual accumulation of damage to biological systems over a lifetime. This
Revolutionizing Cancer Care: How Artificial Intelligence Is Shaping the Future of Treatment and Hope
Cancer continues to be one of the leading causes of death worldwide, with millions of new cases diagnosed each year.
Thrombocytopenia in Cancer: Understanding the Link and Navigating Management
Thrombocytopenia, a condition marked by a low platelet count, is a common yet often under-discussed complication in cancer patients. Platelets
Boosting Cancer Care: The Role of Health Supplements in Enhancing Patient Outcomes
Introduction: A New Approach to Cancer Support In the ever-evolving landscape of cancer treatment, healthcare professionals are constantly searching for